FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048227011> ?p ?o ?g. }

• W3048227011 endingPage "2653" @default.
• W3048227011 startingPage "2646" @default.
• W3048227011 abstract "BackgroundCOVID‐19 is associated with a substantial risk of venous thrombotic events, even in the presence of adequate thromboprophylactic therapy.ObjectivesWe aimed to better characterize the hypercoagulable state of COVID‐19 patients in patients receiving anticoagulant therapy.MethodsWe took plasma samples of 23 patients with COVID‐19 who were on prophylactic or intensified anticoagulant therapy. Twenty healthy volunteers were included to establish reference ranges.ResultsCOVID‐19 patients had a mildly prolonged prothrombin time, high von Willebrand factor levels and low ADAMTS13 activity. Most rotational thromboelastometry parameters were normal, with a hypercoagulable maximum clot firmness in part of the patients. Despite detectable anti‐activated factor X activity in the majority of patients, ex vivo thrombin generation was normal, and in vivo thrombin generation elevated as evidenced by elevated levels of thrombin‐antithrombin complexes and D‐dimers. Plasma levels of activated factor VII were lower in patients, and levels of the platelet activation marker soluble CD40 ligand were similar in patients and controls. Plasmin‐antiplasmin complex levels were also increased in patients despite an in vitro hypofibrinolytic profile.ConclusionsCOVID‐19 patients are characterized by normal in vitro thrombin generation and enhanced clot formation and decreased fibrinolytic potential despite the presence of heparin in the sample. Anticoagulated COVID‐19 patients have persistent in vivo activation of coagulation and fibrinolysis, but no evidence of excessive platelet activation. Ongoing activation of coagulation despite normal to intensified anticoagulant therapy indicates studies on alternative antithrombotic strategies are urgently required." @default.
• W3048227011 created "2020-08-13" @default.
• W3048227011 creator A5000717149 @default.
• W3048227011 creator A5010287322 @default.
• W3048227011 creator A5029344931 @default.
• W3048227011 creator A5036427789 @default.
• W3048227011 creator A5041225333 @default.
• W3048227011 creator A5063963121 @default.
• W3048227011 creator A5074302578 @default.
• W3048227011 creator A5081882772 @default.
• W3048227011 date "2020-10-01" @default.
• W3048227011 modified "2023-10-14" @default.
• W3048227011 title "In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation" @default.
• W3048227011 cites W2042275984 @default.
• W3048227011 cites W2043756611 @default.
• W3048227011 cites W2051015369 @default.
• W3048227011 cites W2098100901 @default.
• W3048227011 cites W2128916601 @default.
• W3048227011 cites W2259998258 @default.
• W3048227011 cites W2888848488 @default.
• W3048227011 cites W2909761474 @default.
• W3048227011 cites W2909810655 @default.
• W3048227011 cites W2971304637 @default.
• W3048227011 cites W3008461878 @default.
• W3048227011 cites W3013486442 @default.
• W3048227011 cites W3015863623 @default.
• W3048227011 cites W3016123694 @default.
• W3048227011 cites W3016538780 @default.
• W3048227011 cites W3016595631 @default.
• W3048227011 cites W3016641669 @default.
• W3048227011 cites W3016965546 @default.
• W3048227011 cites W3018507926 @default.
• W3048227011 cites W3019046211 @default.
• W3048227011 cites W3021056079 @default.
• W3048227011 cites W3022564719 @default.
• W3048227011 cites W3024270855 @default.
• W3048227011 cites W3025313574 @default.
• W3048227011 cites W3027918021 @default.
• W3048227011 cites W3028972703 @default.
• W3048227011 cites W3028989873 @default.
• W3048227011 cites W3126061642 @default.
• W3048227011 doi "https://doi.org/10.1111/jth.15043" @default.
• W3048227011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7436627" @default.
• W3048227011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32762118" @default.
• W3048227011 hasPublicationYear "2020" @default.
• W3048227011 type Work @default.
• W3048227011 sameAs 3048227011 @default.
• W3048227011 citedByCount "102" @default.
• W3048227011 countsByYear W30482270112020 @default.
• W3048227011 countsByYear W30482270112021 @default.
• W3048227011 countsByYear W30482270112022 @default.
• W3048227011 countsByYear W30482270112023 @default.
• W3048227011 crossrefType "journal-article" @default.
• W3048227011 hasAuthorship W3048227011A5000717149 @default.
• W3048227011 hasAuthorship W3048227011A5010287322 @default.
• W3048227011 hasAuthorship W3048227011A5029344931 @default.
• W3048227011 hasAuthorship W3048227011A5036427789 @default.
• W3048227011 hasAuthorship W3048227011A5041225333 @default.
• W3048227011 hasAuthorship W3048227011A5063963121 @default.
• W3048227011 hasAuthorship W3048227011A5074302578 @default.
• W3048227011 hasAuthorship W3048227011A5081882772 @default.
• W3048227011 hasBestOaLocation W30482270111 @default.
• W3048227011 hasConcept C126322002 @default.
• W3048227011 hasConcept C150903083 @default.
• W3048227011 hasConcept C181199279 @default.
• W3048227011 hasConcept C185592680 @default.
• W3048227011 hasConcept C203014093 @default.
• W3048227011 hasConcept C207001950 @default.
• W3048227011 hasConcept C26291073 @default.
• W3048227011 hasConcept C26809991 @default.
• W3048227011 hasConcept C2776825266 @default.
• W3048227011 hasConcept C2777015399 @default.
• W3048227011 hasConcept C2777292125 @default.
• W3048227011 hasConcept C2777557582 @default.
• W3048227011 hasConcept C2778382381 @default.
• W3048227011 hasConcept C2779026020 @default.
• W3048227011 hasConcept C2779394231 @default.
• W3048227011 hasConcept C2781071845 @default.
• W3048227011 hasConcept C3018697912 @default.
• W3048227011 hasConcept C55493867 @default.
• W3048227011 hasConcept C71924100 @default.
• W3048227011 hasConcept C86803240 @default.
• W3048227011 hasConcept C89560881 @default.
• W3048227011 hasConcept C90924648 @default.
• W3048227011 hasConcept C98274493 @default.
• W3048227011 hasConceptScore W3048227011C126322002 @default.
• W3048227011 hasConceptScore W3048227011C150903083 @default.
• W3048227011 hasConceptScore W3048227011C181199279 @default.
• W3048227011 hasConceptScore W3048227011C185592680 @default.
• W3048227011 hasConceptScore W3048227011C203014093 @default.
• W3048227011 hasConceptScore W3048227011C207001950 @default.
• W3048227011 hasConceptScore W3048227011C26291073 @default.
• W3048227011 hasConceptScore W3048227011C26809991 @default.
• W3048227011 hasConceptScore W3048227011C2776825266 @default.
• W3048227011 hasConceptScore W3048227011C2777015399 @default.
• W3048227011 hasConceptScore W3048227011C2777292125 @default.
• W3048227011 hasConceptScore W3048227011C2777557582 @default.
• W3048227011 hasConceptScore W3048227011C2778382381 @default.

• next